These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 20659323)
21. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300. Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244 [TBL] [Abstract][Full Text] [Related]
22. IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis. Ning Y; Riggins RB; Mulla JE; Chung H; Zwart A; Clarke R Mol Cancer Ther; 2010 May; 9(5):1274-85. PubMed ID: 20457620 [TBL] [Abstract][Full Text] [Related]
23. Colon epithelial cell differentiation is inhibited by constitutive c-myb expression or mutant APC plus activated RAS. Ramsay RG; Ciznadija D; Sicurella C; Reyes N; Mitchelhill K; Darcy PK; D'Abaco G; Mantamadiotis T DNA Cell Biol; 2005 Jan; 24(1):21-9. PubMed ID: 15684716 [TBL] [Abstract][Full Text] [Related]
24. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development. Thaler S; Schmidt M; Schad A; Sleeman JP Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866 [TBL] [Abstract][Full Text] [Related]
25. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol. Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578 [TBL] [Abstract][Full Text] [Related]
26. Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro. Jansen GH; Franke HR; Wolbers F; Brinkhuis M; Vermes I Climacteric; 2008 Aug; 11(4):315-21. PubMed ID: 18645697 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Sumi T; Tsuneyoshi N; Nakatsuji N; Suemori H Oncogene; 2007 Aug; 26(38):5564-76. PubMed ID: 17369859 [TBL] [Abstract][Full Text] [Related]
28. Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships. Schomburg C; Schuehly W; Da Costa FB; Klempnauer KH; Schmidt TJ Eur J Med Chem; 2013 May; 63():313-20. PubMed ID: 23501116 [TBL] [Abstract][Full Text] [Related]
29. Nemo-like kinase associated with proliferation and apoptosis by c-Myb degradation in breast cancer. Huang Y; Jiang Y; Lu W; Zhang Y PLoS One; 2013; 8(7):e69148. PubMed ID: 23935942 [TBL] [Abstract][Full Text] [Related]
30. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine. Sui M; Jiang D; Hinsch C; Fan W Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437 [TBL] [Abstract][Full Text] [Related]
31. MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells. Yang RM; Nanayakkara D; Kalimutho M; Mitra P; Khanna KK; Dray E; Gonda TJ Oncogene; 2019 Jun; 38(26):5239-5249. PubMed ID: 30971760 [TBL] [Abstract][Full Text] [Related]
32. Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. Thorner AR; Parker JS; Hoadley KA; Perou CM PLoS One; 2010 Oct; 5(10):e13073. PubMed ID: 20949095 [TBL] [Abstract][Full Text] [Related]
33. BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells. Nehra R; Riggins RB; Shajahan AN; Zwart A; Crawford AC; Clarke R FASEB J; 2010 Jun; 24(6):2040-55. PubMed ID: 20154269 [TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors. Chang J; Sui M; Fan W Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518 [TBL] [Abstract][Full Text] [Related]
36. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671 [TBL] [Abstract][Full Text] [Related]
37. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Wickramasinghe NS; Manavalan TT; Dougherty SM; Riggs KA; Li Y; Klinge CM Nucleic Acids Res; 2009 May; 37(8):2584-95. PubMed ID: 19264808 [TBL] [Abstract][Full Text] [Related]
38. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells. Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729 [TBL] [Abstract][Full Text] [Related]
39. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells. Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335 [TBL] [Abstract][Full Text] [Related]
40. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. Xie D; Miller CW; O'Kelly J; Nakachi K; Sakashita A; Said JW; Gornbein J; Koeffler HP J Biol Chem; 2001 Apr; 276(17):14187-94. PubMed ID: 11297518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]